Evaluation of selected features of Staphylococcus cohnii enabling colonization of humans
Language English Country United States Media print
Document type Evaluation Study, Journal Article, Research Support, Non-U.S. Gov't
PubMed
12503405
DOI
10.1007/bf02818799
Knihovny.cz E-resources
- MeSH
- Anti-Bacterial Agents pharmacology MeSH
- Bacteriological Techniques MeSH
- Endopeptidases metabolism MeSH
- Intensive Care Units * MeSH
- Infant MeSH
- Skin chemistry microbiology MeSH
- Humans MeSH
- Lipase metabolism MeSH
- Fatty Acids pharmacology MeSH
- Microbial Sensitivity Tests MeSH
- Staphylococcal Infections microbiology MeSH
- Staphylococcus drug effects growth & development metabolism MeSH
- Iron metabolism MeSH
- Environment * MeSH
- Check Tag
- Infant MeSH
- Humans MeSH
- Publication type
- Journal Article MeSH
- Evaluation Study MeSH
- Research Support, Non-U.S. Gov't MeSH
- Names of Substances
- Anti-Bacterial Agents MeSH
- Endopeptidases MeSH
- Lipase MeSH
- Fatty Acids MeSH
- Iron MeSH
Based on iron utilization, sensitivity to skin fatty acids, lipolytic and proteolytic activity the potential abilities of Staphylococcus cohnii strains to colonize humans were evaluated. The investigation included 60 strains that belong to both subspecies, viz. S. cohnii ssp. cohnii and S. cohnii ssp. urealyticus. Strains were isolated from different sources of the Intensive Care Unit and from non-hospital environment. Most of the strains were multiple antibiotic-resistant. Strains of both subspecies revealed a relatively low iron requirement. These strains were capable of utilizing iron bound in oxo acids and from host iron-binding proteins. S. cohnii ssp. urealyticus were more effective in iron uptake than S. cohnii ssp. cohnii. All investigated strains revealed sensitivity to skin fatty acids, but S. cohnii ssp. urealyticus strains were more resistant. Special features of strains of this subspecies promote colonization of humans.
See more in PubMed
Eur J Clin Microbiol Infect Dis. 1995 Oct;14(10):904-8 PubMed
J Med Microbiol. 1995 Jul;43(1):26-32 PubMed
J Hosp Infect. 1996 Mar;32(3):217-27 PubMed
J Hosp Infect. 2000 Jun;45(2):145-54 PubMed
Med Dosw Mikrobiol. 1997;49(1-2):45-53 PubMed
Infect Immun. 1981 Aug;33(2):555-64 PubMed
FEMS Microbiol Lett. 1989 Nov;53(1-2):123-7 PubMed
J Bacteriol. 1993 May;175(9):2727-33 PubMed
Infect Immun. 1988 Apr;56(4):721-5 PubMed
J Med Microbiol. 1981 Feb;14(1):41-9 PubMed
J Am Acad Dermatol. 1986 Feb;14(2 Pt 1):221-5 PubMed
Appl Environ Microbiol. 1992 Feb;58(2):624-9 PubMed
Int J Syst Bacteriol. 1999 Apr;49 Pt 2:489-502 PubMed
J Gen Microbiol. 1976 Jun;94(2):290-6 PubMed
Antonie Van Leeuwenhoek. 1978;44(3-4):257-67 PubMed
Antimicrob Agents Chemother. 1996 Feb;40(2):302-6 PubMed
Eur J Clin Microbiol Infect Dis. 1999 Jul;18(7):530 PubMed
FEMS Microbiol Rev. 1993 Nov;12(4):325-48 PubMed
J Med Microbiol. 1992 Oct;37(4):232-4 PubMed
Acta Microbiol Pol. 2000;49(2):121-33 PubMed
Cohabitation--relationships of corynebacteria and staphylococci on human skin
Staphylococcus cohnii hemolysins - isolation, purification and properties
Molecular diagnostics of clinically important staphylococci
Plasmids of Staphylococcus cohnii isolated from the intensive-care unit
Aggregation of Lactobacilli and Bifidobacteria with Escherichia coli O157
Potential virulence-associated properties of Plesiomonas shigelloides strains
